Drug-Resistant TB Could Cost World Economy $20B Annually, Needs To Be Treated As Public Health Emergency, Report Says

The Telegraph: Warning over global failure to act on deaths from drug-resistant TB
“The spiraling number of deaths from drug-resistant tuberculosis (DR-TB) is set to cost the world economy nearly $20 billion annually. A report from the Economist Intelligence Unit warned that despite the fact that DR-TB is a huge global health threat, the fight against the disease lags behind others in terms of both money and attention. In low- and middle-income countries, where 97 percent of the TB cases took place in 2018, there was an estimated $3.5 billion shortfall in the total $10 billion budget required to address the disease. … The EIU and Johnson & Johnson report called for the disease to be treated as a public health emergency and said $9 billion was needed to develop new drugs, diagnostics, and vaccines…” (Wallen, 5/9).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.